Butenafine

Butenafine
Clinical data
Trade names	Mentax, Lotrimin Ultra
AHFS/Drugs.com	Monograph
Routes of; administration	Topical (cream)
ATC code	D01AE23 (WHO) ;
Legal status
Legal status	OTC (Lotrimin Ultra), Rx-only (Mentax);
Pharmacokinetic data
Metabolism	Hepatic
Elimination half-life	35–100 hours
Identifiers
	IUPAC name [(4-tert-butylphenyl)methyl](methyl)(naphthalen-1-ylmethyl)amine;
CAS Number	101828-21-1 ;
PubChem CID	2484;
DrugBank	DB01091 ;
ChemSpider	2390 ;
UNII	91Y494NL0X;
KEGG	D07596 ;
ChEBI	CHEBI:3238 ;
ChEMBL	ChEMBL990 ;
CompTox Dashboard (EPA)	DTXSID7040657 ;
Chemical and physical data
Formula	C23H27N
Molar mass	317.476 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES N(C)(Cc1ccc(cc1)C(C)(C)C)Cc3c2ccccc2ccc3;
	InChI InChI=1S/C23H27N/c1-23(2,3)21-14-12-18(13-15-21)16-24(4)17-20-10-7-9-19-8-5-6-11-22(19)20/h5-15H,16-17H2,1-4H3 ; Key:ABJKWBDEJIDSJZ-UHFFFAOYSA-N ;
	(verify)

Butenafine, sold under the brand names Lotrimin Ultra, Mentax, and Butop (In India only), is a synthetic benzylamine derived antifungal drug.

It is structurally related to the allylamine antifungals terbinafine & naftifine.

^ Mylan Pharmaceuticals Inc. "Mentax (butenafine hydrochloride) Cream. Human Prescription Drug Label". dailymed.nlm.nih.gov. National Institutes of Health, U.S. National Library of Medicine, Health & Human Services. Retrieved 24 August 2016.